01:38 PM EST, 11/21/2025 (MT Newswires) -- Health care stocks were higher Friday afternoon, with the NYSE Health Care Index rising 2.5% and the Health Care Select Sector SPDR Fund (XLV) up 2.4%.

The iShares Biotechnology ETF (IBB) climbed 2.2%.

In corporate news, Eli Lilly ( LLY ) shares rose as much as 1.7% on Friday to $1,061.17, touching a market capitalization of $1 trillion. Eli Lilly ( LLY ) became the first pharmaceutical company to achieve the milestone, joining a small group of companies, including eight tech giants, the Financial Times reported.

Novo Nordisk ( NVO ) and Eli Lilly ( LLY ) are set to begin offering their popular GLP-1 drugs to employers at fixed prices, avoiding rebates and fees that typically arise with traditional drug sales channels, Bloomberg reported. Lilly's Zepbound and Novo Nordisk's ( NVO ) Wegovy will be sold to companies through digital health firm Waltz Health starting Jan. 1, the report said. Novo shares added 0.4%.

Sangamo Therapeutics ( SGMO ) shares jumped 8% after it said Friday the US Food and Drug Administration accepted its request for rolling review of a biologics license application for isaralgagene civaparvovec to treat adults with Fabry disease.

HeartBeam ( BEAT ) shares fell 58% after the company reported receiving a "Not Substantially Equivalent" letter from the US Food and Drug Administration regarding the 510(k) application for its 12-Lead Electrocardiogram Synthesis Software.